A twice-yearly injection of this new drug can prevent high-risk populations from catching #HIV. Now the EU has given it a green light. Here’s how #lenacapavir works – and what its manufacturer, Gilead Sciences is doing to broaden access to poorer countries. We also hear from @Winnie Byanyima, Executive Director of @UNAidsglobal, on how the long-acting medication can help alleviate stigma and discrimination. The World Economic Forum’s Health For All initiative aims to foster a world where everyon